Company: SXTPW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003343
Chunk: 196

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 1
Chunk 196
---
 securities underlying unexercised
    options unexercisable (#)  
    Equity incentive plan awards: Number
    of securities underlying unexercised unearned options (#)  
    Option exercise price ($)  
    Option expiration date 
    Number of shares or units of stock
    that have not vested (#)  
    Market value of shares or units of
    stock that have not vested ($) 
  
    Geoffrey
    Dow, President and Chief Executive Officer (Principal Executive Officer)(1)  
     1,000  
             -  
     4,000  
    $60.00  
    July 16, 2034 
           -  
    $        - 
  
    Tyrone
    Miller, Chief Financial Officer (Principal Financial and Accounting Officer)(2)  
     800  
     -  
     3,200  
    $60.00  
    July 16, 2034 
     -  
    $- 
  
    Kristen
    Landon, Chief Commercial Officer(3)  
     834  
     -  
     3,333  
    $6.85  
    September 26, 2034 
     -  
    $- 

    (1)
    Dr. Dow’s options to purchase a total of 5,000 shares of our
    common stock vest annually on the last date of each fiscal year in five equal tranches, with the first vesting date being December
    31, 2024. 

    (2)
    Mr. Miller’s options to purchase a total of 4,000 shares of our
    common stock vest annually on the last date of each fiscal year in five equal tranches, with the first vesting date being December
    31, 2024. 

    (3)
    Ms. Landon’s options to purchase a total of 4,167 shares of our
    common stock vest annually on the last date of each fiscal year in five equal tranches, with the first vesting date being December
    31, 2024. 

2022 Equity Incentive Plan

Overview

On November 22, 2022, our Board and our
stockholders approved the 60 Degrees Pharmaceuticals, Inc. 2022 Equity Incentive Plan. The 2022 Plan governs